Article may be outdated

This article is 11 days old. Some details may have changed since publication.

Science Daily·4 min read·hard

Major trial challenges how doctors decide who really needs statins

Major trial challenges how doctors decide who really needs statins
✦AI Summary

A clinical trial has found that using heart scans to guide statin prescriptions is as effective as traditional risk assessment methods while reducing the number of unnecessary prescriptions. Patients using the scan-based approach also showed higher adherence to their medication.

Why it matters

This research could shift clinical guidelines for cardiovascular disease prevention, potentially improving patient outcomes and reducing medication over-prescription.

✦Dive DeeperCreate a free account to unlock

A major clinical trial has raised new questions about how doctors decide who should take statins to prevent heart attacks and strokes. Researchers found that using heart scans to guide treatment decisions produced the same observed rate of major cardiovascular events as traditional risk assessments, even though the scans led to far fewer recommendations to begin taking statins.

The findings, presented during a Hot Line session at ESC Congress 2026, also revealed a striking difference in how consistently patients took their medication. Those advised to use statins based on calcium buildup in their coronary arteries were substantially more likely to follow their treatment recommendations.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in